文献速递头颈外科

cT1N0口腔鳞癌隐匿性淋巴结转移的术前预测因素:2623例回顾

Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases.
PubMed 文献 · Head Neck · 2018-05-14

基于美国国家癌症数据库回顾性分析接受手术切除及选择性颈淋巴清扫的cT1N0口腔鳞癌患者,发现隐匿性淋巴结转移率为15.1%,女性及肿瘤分化程度是独立预测因素,推荐中低分化者行选择性颈清扫,高分化者可考虑不行。

要点

  • cT1N0口腔鳞癌隐匿性淋巴结转移率为15.1%。
  • 女性及中/低分化是隐匿性淋巴结转移的独立预测因素。
  • 推荐所有中、低分化cT1N0患者行选择性颈清扫,高分化者可考虑观察。

核心结论

  • 性别和肿瘤分化程度显著预测cT1N0口腔鳞癌的隐匿性淋巴结转移。

研究设计与样本

  • 美国国家癌症数据库(NCDB)回顾性分析接受手术切除及选择性颈淋巴清扫的cT1N0口腔鳞癌患者。

主要发现

  • 2623例(15.1%)患者发现隐匿性淋巴结转移。
  • 高分化肿瘤隐匿性淋巴结转移发生率为5.9%,中分化为17.4%,低分化为28.5%(P < .001)。
  • 女性口腔舌癌患者隐匿性淋巴结转移率(19.1%)高于男性(12%;P = .001)。
  • 女性隐匿性淋巴结转移调整OR为1.26(95%CI 1.01-1.59;P = .045)。
  • 中分化调整OR为3.52(95%CI 2.47-5.01;P < .001),低分化调整OR为6.25(95%CI 4.17-9.38;P < .001)。

关键数值与推荐

  • 推荐所有中分化和低分化cT1N0口腔鳞癌行选择性颈淋巴清扫,无论浸润深度。
  • 高分化肿瘤可考虑不行选择性颈淋巴清扫。

临床怎么用

  • 术前评估应结合性别和肿瘤分化程度预测隐匿性淋巴结转移风险,指导选择性颈淋巴清扫决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nodal disease predicts survival in oral cavity squamous cell carcinoma (SCC). Currently, no large studies on predictors of occult nodal disease in cT1N0 oral cavity SCC exist. METHODS: The National Cancer Database (NCDB) review for cT1N0 oral cavity SCC with surgical resection and elective neck dissection (END). RESULTS: The number of patients found with occult nodal disease was 2623 (15.1%). In multivariable regression, female sex and tumor differentiation predict occult nodal disease. Occult nodal disease incidence was 5.9% in well-differentiated tumors, 17.4% in moderately differentiated tumors, and 28.5% in poorly differentiated tumor (P < .001). Women with oral tongue tumors had higher occult nodal disease (19.1%) than men (12%; P = .001). Adjusted odds ratios (aORs) for occult nodal disease in women were: aOR 1.26; 95% confidence interval (CI) 1.01-1.59; P = .045; moderately differentiated aOR 3.52; 95% CI 2.47-5.01; P < .001; and poorly differentiated aOR 6.25; 95% CI 4.17-9.38; P < .001. CONCLUSION: Sex and tumor differentiation significantly predict occult nodal disease. END is recommended for all moderately and poorly differentiated cT1N0 oral cavity SCC, regardless of the depth of invasion. One can consider not performing END in well-differentiated tumors.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Zhan KY, Morgan PF, Neskey DM, et al. Preoperative predictors of occult nodal disease in cT1N0 oral cavity squamous cell carcinoma: Review of 2623 cases. Head Neck. 2018. PMID: 29761586. doi:10.1002/hed.25178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。